Hepatology Startups in APAC

There are 14 Hepatology digital health ventures in APAC. The total venture volume has expanded at a CAGR of 3.0% over the past 5 years. The ventures have an average venture maturity score of 53.8.

In total, $671.28M of digital health venture capital has been raised across 49 funding deals.

Here is a list of 10 promising HealthTech startups!

Last Updated: January 17, 2022

Ventures

ShowEntries

Startup	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding	Track
Aigan Bao (爱肝宝)	EHR / PHR	China	$ 123.46 B	$ 123.46 B	Angel	$ 0.72 M	Toggle
Berry Genomics (贝瑞和康)	Omics Related Diagnosis	China	$ 123.46 B	$ 123.46 B	IPO	$ 624.85 M	Toggle
Biosense Technologies	Diagnosis Tools	India	$ 123.46 B	$ 123.46 B	Seed	$ 1.00 M	Toggle
Chengyi Health (诚医健康)	Teleconsultation	China	$ 123.46 B	$ 123.46 B		undisclosed	Toggle
CureApp (CureApp)	Digital Therapeutics	Japan	$ 123.46 B	$ 123.46 B	Series D	$ 52.24 M	Toggle
Fibronostics	Diagnosis Tools	United States	$ 123.46 B	$ 123.46 B	Series A	$ 8.00 M	Toggle
Genome Wisdom (志诺维思)	Medical Imaging	China	$ 123.46 B	$ 123.46 B	Series B	$ 8.52 M	Toggle
Genuity Science (明码科技)	Omics Related Research	China	$ 123.46 B	$ 123.46 B	M&A	$ 100.00 M	Toggle
Geometry Healthtech (几何科技)	Remote Monitoring Devices	China	$ 123.46 B	$ 123.46 B	Series A	undisclosed	Toggle
Gigaceuticals (亿药科技)	Drug Discovery	China	$ 123.46 B	$ 123.46 B	Seed	$ 1.50 M	Toggle

Showing 1 to 10 of 14 entries